Drug intelligence / Profile preview

AMVITA

Development stage: Unknown
Lead developer: Amgen
Modality: Recombinant Proteins and Enzymes
Administration: Oral

Overview

AMVITA is a chocolate-flavored protein powder supplement developed by Amvia Biotech. It is intended for use as a nutritional and protein supplement to support dietary requirements and muscle health. Administered orally, the product is typically supplied in a 200 gm powder formulation. As a nutraceutical, it provides a concentrated source of protein, which is essential for various physiological functions, including tissue repair and enzyme production.

Brand names: AMVITA
Other names: Chocolate Flavour Protein Powder

Targets

TNFA (Tumor necrosis factor alpha (soluble))LTA (Lymphotoxin-alpha)

Beyond the preview

Go deeper on AMVITA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AMVITA.

Explore the full profile